Gregory J. Keir

2.9k total citations
41 papers, 1.5k citations indexed

About

Gregory J. Keir is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Gregory J. Keir has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Gregory J. Keir's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (29 papers), Sarcoidosis and Beryllium Toxicity Research (13 papers) and Pulmonary Hypertension Research and Treatments (13 papers). Gregory J. Keir is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (29 papers), Sarcoidosis and Beryllium Toxicity Research (13 papers) and Pulmonary Hypertension Research and Treatments (13 papers). Gregory J. Keir collaborates with scholars based in Australia, United Kingdom and United States. Gregory J. Keir's co-authors include Athol U. Wells, Elisabetta Renzoni, David M. Hansell, Toby M. Maher, Nicola Sverzellati, Simon Walsh, Andrew G. Nicholson, Anand Devaraj, Christopher P. Denton and Nicole Goh and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.

In The Last Decade

Gregory J. Keir

38 papers receiving 1.5k citations

Peers

Gregory J. Keir

PRM

PHYSI

PFM

EPIDE

RHEUM

Maria Kokosi United Kingdom

Tristan J. Huie United States

P. Latsi Greece

Kiran Batra United States

Keishi Sugino Japan

Quitterie Reynaud France

Yimy F. Medina Colombia

Angelo Carloni Italy

Andrea V. Arrossi United States

Louis DePalo United States

Maria Kokosi United Kingdom

Gregory J. Keir

1.4k ×1.1

PRM

550 ×1.0

PHYSI

216 ×0.6

PFM

132 ×0.4

EPIDE

99 ×0.6

RHEUM

Citations per year, relative to Gregory J. Keir Gregory J. Keir (= 1×) peers Maria Kokosi

Countries citing papers authored by Gregory J. Keir

Since Specialization

Citations

This map shows the geographic impact of Gregory J. Keir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory J. Keir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory J. Keir more than expected).

Fields of papers citing papers by Gregory J. Keir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory J. Keir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory J. Keir. The network helps show where Gregory J. Keir may publish in the future.

Co-authorship network of co-authors of Gregory J. Keir

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory J. Keir. A scholar is included among the top collaborators of Gregory J. Keir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory J. Keir. Gregory J. Keir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tan, Dino B.A., Wendy A. Cooper, Helen E. Jo, et al.. (2025). Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients. Respirology. 30(6). 504–514. 2 indexed citations

Yang, Nan, Francesco Federico, Stephen M. Humphries, et al.. (2025). Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective study. European Respiratory Journal. 66(4). 2500981–2500981.

Mackintosh, John A., Gregory J. Keir, Lauren Troy, et al.. (2024). Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology. 29(2). 105–135. 26 indexed citations

Barnes, Hayley, Tamera J. Corte, Gregory J. Keir, et al.. (2024). Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand. Respirology. 29(12). 1023–1046. 1 indexed citations

Samaranayake, Chinthaka B., John W. Upham, Khoa D. Tran, et al.. (2023). Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study. BMJ Open Respiratory Research. 10(1). e001637–e001637. 4 indexed citations

Samaranayake, Chinthaka B., Aleksander Kempny, Peter T. Bell, et al.. (2022). Right heart strain assessment on CTPA following acute pulmonary embolism: Interobserver variability between expert radiologists and physicians. Respiratory Medicine. 200. 106928–106928. 4 indexed citations

Samaranayake, Chinthaka B., Gregory J. Keir, Colm McCabe, et al.. (2021). Thrombolysis for massive pulmonary embolisms in morbid obesity: a multisite case–control study. ERJ Open Research. 7(1). 762–2020. 2 indexed citations

Lee, Joanna Y.T., Gabriella Tikellis, Tamera J. Corte, et al.. (2020). The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review. European Respiratory Review. 29(156). 190125–190125. 54 indexed citations

Jo, Helen E., Tamera J. Corte, Ian Glaspole, et al.. (2019). Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry. BMC Pulmonary Medicine. 19(1). 84–84. 22 indexed citations

10.

Keir, Gregory J., Stephen J. Wort, Maria Kokosi, et al.. (2018). Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization. Respirology. 23(7). 687–694. 45 indexed citations

11.

Bax, Simon, Charlène Bredy, Aleksander Kempny, et al.. (2018). A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease. ERJ Open Research. 4(2). 124–2017. 25 indexed citations

12.

Saunders, Peter, Vicky Tsipouri, Gregory J. Keir, et al.. (2017). Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial. Trials. 18(1). 275–275. 115 indexed citations

13.

Jo, Helen E., Ian Glaspole, Christopher Grainge, et al.. (2017). Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. European Respiratory Journal. 49(2). 1601592–1601592. 161 indexed citations

14.

Keir, Gregory J., Arjun Nair, Stamatia Giannarou, et al.. (2015). Pulmonary Vasospasm in Systemic Sclerosis: Noninvasive Techniques for Detection. Pulmonary Circulation. 5(3). 498–505. 2 indexed citations

15.

Keir, Gregory J., Tamera J. Corte, Konstantinos Dimopoulos, et al.. (2014). Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia. European Respiratory Journal. 44(Suppl 58). P2335–P2335.

16.

Corte, Tamera J., Gregory J. Keir, Konstantinos Dimopoulos, et al.. (2014). Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia. American Journal of Respiratory and Critical Care Medicine. 190(2). 208–217. 153 indexed citations

17.

Wells, Athol U., Nicola Sverzellati, Gregory J. Keir, et al.. (2014). An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. The Lancet Respiratory Medicine. 2(2). 123–130. 150 indexed citations

18.

Keir, Gregory J., Tamera J. Corte, Lisa Parfitt, et al.. (2013). Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia: A randomized, double-blind, placebo-controlled study. European Respiratory Journal. 42(Suppl 57). 1779–1779. 3 indexed citations

19.

Keir, Gregory J., Benjamin Garfield, David M. Hansell, et al.. (2013). Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis. Thorax. 69(3). 287–288. 26 indexed citations

20.

Patel, Amit, Richard J. Siegert, Gregory J. Keir, et al.. (2013). The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease. Respiratory Medicine. 107(9). 1438–1443. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact